Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | R273C |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 R273C is a hotspot mutation that lies within the DNA binding domain of the Tp53 protein (PMID: 22713868). R273C results in increased proliferation, migration, invasion, and protein stability, and altered subcellular localization in culture (PMID: 37030635), decreased activation of wild-type Tp53 target genes, as well as aberrant activation of gene expression, and increased cell proliferation and migration in culture (PMID: 23264849, PMID: 23612969, PMID: 16861262). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon8 TP53 R273X TP53 R273C TP53 mutant TP53 inact mut TP53 R273C |
Transcript | NM_000546.6 |
gDNA | chr17:g.7673803G>A |
cDNA | c.817C>T |
Protein | p.R273C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126113.2 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7673803G>A | c.817C>T | p.R273C | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|